Search Results - "TANIOKA HIROAKI" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08

Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08

by Masuishi, Toshiki, Tsuji, Akihito, Kotaka, Masahito, Nakamura, Masato, Kochi, Mitsugu, Takagane, Akinori, Shimada, Ken, Denda, Tadamichi, Segawa, Yoshihiko, Tanioka, Hiroaki, Hara, Hiroki, Sagawa, Tamotsu, Watanabe, Takanori, Takahashi, Takao, Negoro, Yuji, Manaka, Dai, Fujita, Hideto, Suto, Takeshi, Takeuchi, Masahiro, Ichikawa, Wataru, Fujii, Masashi
Published in British journal of cancer (01.11.2020)

Get full text

Journal Article

Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles

Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles

by Yasui, Kazuya, Toshima, Toshiaki, Inada, Ryo, Umeda, Yuzo, Yano, Shuya, Tanioka, Hiroaki, Nyuya, Akihiro, Fujiwara, Toshiyoshi, Yamada, Takeshi, Naomoto, Yoshio, Goel, Ajay, Nagasaka, Takeshi
Published in Molecular cancer (03.01.2024)

Get full text

Journal Article

Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade

Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade

by Toshima, Toshiaki, Tanioka, Hiroaki, Mori, Yoshiko, Tanaka, Takehiro, Yasui, Kazuya, Kimura, Keisuke, Umeda, Yuzo, Fujiwara, Toshiyoshi, Nyuya, Akihiro, Yano, Shuya, Nagasaka, Takeshi
Published in Oncology (01.02.2023)

Get more information

Journal Article

Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial

Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial

by Ooki, Akira, Morita, Satoshi, Tsuji, Akihito, Iwamoto, Shigeyoshi, Hara, Hiroki, Tanioka, Hiroaki, Satake, Hironaga, Kataoka, Masato, Kotaka, Masahito, Kagawa, Yoshinori, Nakamura, Masato, Shingai, Tatsushi, Ishikawa, Masashi, Miyake, Yasuhiro, Suto, Takeshi, Hashiguchi, Yojiro, Yabuno, Taichi, Ando, Masahiko, Sakamoto, Junichi, Yamaguchi, Kensei
Published in BMC cancer (28.06.2022)

Get full text

Journal Article

A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI)

A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI)

by Shinozaki, Katsunori, Yamada, Takeshi, Nasu, Junichiro, Matsumoto, Toshihiko, Yuasa, Yasuhiro, Shiraishi, Takeshi, Nagano, Hiroaki, Moriyama, Ichiro, Fujiwara, Toshiyoshi, Miguchi, Masashi, Yoshida, Ryosuke, Nozaka, Kimiyasu, Tanioka, Hiroaki, Nagasaka, Takeshi, Kurisu, Yasuro, Kobayashi, Michiya, Tsuchihashi, Kenji, Inukai, Michio, Kikuchi, Takashi, Nishina, Tomohiro
Published in International journal of clinical oncology (01.02.2021)

Get full text

Journal Article

The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)

The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)

by Tanioka, Hiroaki, Nagasaka, Takeshi, Uno, Futoshi, Inoue, Masafumi, Okita, Hiroyuki, Katata, Yosuke, Kanzaki, Hiromitsu, Kuramochi, Hidekazu, Satake, Hironaga, Shindo, Yoshiaki, Doi, Akira, Nasu, Jyunichiro, Yamashita, Haruhiro, Yamaguchi, Yoshiyuki
Published in BMC cancer (11.10.2019)

Get full text

Journal Article

Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study

Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study

by Kato, Takeshi, Kagawa, Yoshinori, Kuboki, Yasutoshi, Gamoh, Makio, Komatsu, Yoshito, Yasui, Hirofumi, Satake, Hironaga, Oki, Eiji, Tanioka, Hiroaki, Kotaka, Masahito, Makiyama, Akitaka, Denda, Tadamichi, Goto, Masahiro, Yoshino, Takayuki, Yamazaki, Kentaro, Soeda, Junpei, Shibuya, Kazunori, Iwata, Masaru, Oba, Koji, Yamaguchi, Kensei
Published in International journal of clinical oncology (01.07.2021)

Get full text

Journal Article

Adoptive immunotherapy for gastric cancer using zoledronate‑activated killer cells: A prospective observational study

Adoptive immunotherapy for gastric cancer using zoledronate‑activated killer cells: A prospective observational study

by Yamaguchi, Yoshiyuki, Katata, Yousuke, Sano, Fuminori, Tanioka, Hiroaki, Okawaki, Makoto, Yamamura, Masahiro, Nagasaka, Takeshi
Published in Molecular and clinical oncology (01.11.2020)

Get full text

Journal Article

Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study)

Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study)

by Suzuki, Nobuaki, Hazama, Shoichi, Nagasaka, Takeshi, Tanioka, Hiroaki, Iwamoto, Yasuo, Negoro, Yuji, Yamauchi, Masami, Kobayashi, Michiya, Okuda, Hiroshi, Fujishima, Noriaki, Nishimura, Taku, Yamanaka, Naoki, Toyota, Kazuhiro, Mori, Yoshiko, Nakagami, Yuki, Shimokawa, Mototsugu, Nagano, Hiroaki, Okajima, Masazumi
Published in International journal of clinical oncology (01.10.2019)

Get full text

Journal Article

Prognostic Nutritional Index as a Predictor of Postoperative Outcome in Patients Aged 85 Years or Older After Colorectal Cancer Surgery

Prognostic Nutritional Index as a Predictor of Postoperative Outcome in Patients Aged 85 Years or Older After Colorectal Cancer Surgery

by Tsuruta, Atsushi, Watanabe, Yusaku, Mineta, Shumei, Tanioka, Hiroaki, Nagasaka, Takeshi, Fujiwara, Yoshinori, Ueno, Tomio
Published in Indian journal of surgery (01.10.2020)

Get full text

Journal Article

Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer

Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer

by Sunakawa, Yu, Mogushi, Kaoru, Lenz, Heinz-Josef, Zhang, Wu, Tsuji, Akihito, Takahashi, Takehiro, Denda, Tadamichi, Shimada, Ken, Kochi, Mitsugu, Nakamura, Masato, Kotaka, Masahito, Segawa, Yoshihiko, Tanioka, Hiroaki, Negoro, Yuji, Moran, Miriana, Astrow, Stephanie H, Hsiang, Jack, Stephens, Craig, Fujii, Masashi, Ichikawa, Wataru
Published in Molecular cancer therapeutics (01.12.2018)

Get full text

Journal Article

Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety

Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety

by Tanioka, Hiroaki, Honda, Michitaka, Tanaka, Chihiro, Morita, Yoshitaka, Ishibashi, Keiichiro, Kato, Takeshi, Matsuda, Chu, Kataoka, Masato, Satake, Hironaga, Munemoto, Yoshinori, Kobayashi, Kenji, Takahashi, Masazumi, Nakata, Ken, Sakamoto, Junichi, Oba, Koji, Mishima, Hideyuki
Published in International journal of clinical oncology (01.07.2019)

Get full text

Journal Article

Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial

Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial

by Ooki, Akira, Morita, Satoshi, Iwamoto, Shigeyoshi, Hara, Hiroki, Tanioka, Hiroaki, Satake, Hironaga, Kataoka, Masato, Kotaka, Masahito, Kagawa, Yoshinori, Nakamura, Masato, Shingai, Tatsushi, Ishikawa, Masashi, Miyake, Yasuhiro, Suto, Takeshi, Hashiguchi, Yojiro, Yabuno, Taichi, Sakamoto, Junichi, Tsuji, Akihito, Ando, Masahiko, Yamaguchi, Kensei
Published in Cancer medicine (Malden, MA) (01.03.2020)

Get full text

Journal Article

Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer

Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer

by Taniguchi, Fumitaka, Nyuya, Akihiro, Toshima, Toshiaki, Yasui, Kazuya, Mori, Yoshiko, Okawaki, Makoto, Kishimoto, Hiroyuki, Umeda, Yuzo, Fujiwara, Toshiyoshi, Tanioka, Hiroaki, Yamaguchi, Yoshiyuki, Goel, Ajay, Nagasaka, Takeshi
Published in Future science OA (01.12.2021)

Get full text

Journal Article

A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial

A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial

by Iwamoto, Shigeyoshi, Ooki, Akira, Morita, Satoshi, Hara, Hiroki, Tanioka, Hiroaki, Satake, Hironaga, Kataoka, Masato, Kotaka, Masahito, Kagawa, Yoshinori, Nakamura, Masato, Shingai, Tatsushi, Ishikawa, Masashi, Miyake, Yasuhiro, Sudo, Takeshi, Hashiguchi, Yojiro, Yabuno, Taichi, Sakamoto, Junichi, Tsuji, Akihito, Ando, Masahiko, Yamaguchi, Kensei
Published in Cancer medicine (Malden, MA) (01.09.2018)

Get full text

Journal Article

$S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)$

S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)

by Miyamoto, Yuji, Tsuji, Akihito, Tanioka, Hiroaki, Maekawa, Soichiro, Kawanaka, Hirofumi, Kitazono, Masaki, Oki, Eiji, Emi, Yasunori, Murakami, Hidetsugu, Ogata, Yutaka, Saeki, Hiroshi, Shimokawa, Mototsugu, Natsugoe, Shoji, Akagi, Yoshito, Baba, Hideo, Maehara, Yoshihiko
Published in International journal of clinical oncology (01.08.2016)

Get full text

Journal Article

CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer

CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer

by Sunakawa, Yu, Tsuji, Akihito, Denda, Tadamichi, Segawa, Yoshihiko, Negoro, Yuji, Shimada, Ken, Kochi, Mitsugu, Nakamura, Masato, Kotaka, Masahito, Tanioka, Hiroaki, Takagane, Akinori, Tani, Satoshi, Yamaguchi, Tatsuro, Watanabe, Takanori, Takeuchi, Masahiro, Fujii, Masashi, Ichikawa, Wataru
Published in Targeted oncology (01.12.2017)

Get full text

Journal Article

Introduction

Introduction

by Yamaguchi, Yoshiyuki, Katata, Yosuke, Okawaki, Makoto, Yamamura, Masahiro, Tanioka, Hiroaki, Nagasaka, Takeshi
Published in Gan to kagaku ryoho (01.07.2018)

Get more information

Journal Article

DISPLAY DEVICE, DISPLAY CONTROL METHOD, AND PROGRAM

DISPLAY DEVICE, DISPLAY CONTROL METHOD, AND PROGRAM

by TANIOKA HIROAKI
Year of Publication 06.12.2023

Get full text

Patent

A Case of Long-Term Survival after Para-Aortic Lymph Node Recurrence Following the Curative Resection of Gastric Cancer Treated Using Multimodality Therapy Including Salvage Surgery

A Case of Long-Term Survival after Para-Aortic Lymph Node Recurrence Following the Curative Resection of Gastric Cancer Treated Using Multimodality Therapy Including Salvage Surgery

by Noumi, Taku, Ishizaki, Masahiro, Tanioka, Hiroaki, Yoshikawa, Chihiro, Kawasaki, Kento, Mushiaki, Yasushi, Iga, Norichika, Yoshida, Ryosuke, Waki, Naohisa, Kawai, Hiroshi, Uno, Futoshi, Nishi, Hideyuki, Yamashita, Kazuki, Sonobe, Hiroshi
Published in Gan to kagaku ryoho (01.12.2019)

Get more information

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[17]